IRON BINDING CAPACITY UNSATURATED DECREASED

This adverse event was reported 20 times

IRON BINDING CAPACITY UNSATURATED DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LINCOMYCIN HYDROCHLORIDE 1 0.0034
1 BUTALBITAL AND ACETAMINOPHEN 1 0.0016
2 DIFLUPREDNATE OPHTHALMIC 1 0.0011
3 PSYLLIUM HUSK 1 0.0007
4 FERRIC CITRATE 1 0.0005
5 UREA 1 0.0005
6 EPOETIN ALFA-EPBX 1 0.0004
7 DEFERIPRONE 1 0.0003
8 DIFLUPREDNATE 1 0.0003
9 EPOETIN ALFA 2 0.0002
See all drugs enriched for association with IRON BINDING CAPACITY UNSATURATED DECREASED

IRON BINDING CAPACITY UNSATURATED DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Quinolone Antimicrobial [EPC] 1 0.0001
1 Vitamin D3 Analog [EPC] 2 0.0001
2 Barbiturate [EPC] 1 0.0001
3 Parenteral Iron Replacement [EPC] 1 0.0001
4 Bile Acid [EPC] 1 0.0000
5 Antimycobacterial [EPC] 1 0.0000
6 Iron Chelator [EPC] 1 0.0000
7 Provitamin D2 Compound [EPC] 1 0.0000
8 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
See all drug classes enriched for association with IRON BINDING CAPACITY UNSATURATED DECREASED